State Of Wisconsin Investment Board Phathom Pharmaceuticals, Inc. Transaction History
State Of Wisconsin Investment Board
- $36.6 Billion
- Q1 2025
A detailed history of State Of Wisconsin Investment Board transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 99,776 shares of PHAT stock, worth $473,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,776
Previous 132,269
24.57%
Holding current value
$473,936
Previous $1.07 Million
41.81%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PHAT
# of Institutions
152Shares Held
66.6MCall Options Held
94KPut Options Held
55.5K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$48 Million3.99% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$35.5 Million12.73% of portfolio
-
Jennison Associates LLC7.04MShares$33.5 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA3.65MShares$17.3 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$16.6 Million27.15% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $186M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...